In endometrial carcinoma, CHD4 has been reported to have both tumor suppressive [20] and oncogenic activity [47], supporting the notion that CHD4 gene dosage may be key to understanding the context-dependent CHD4 activity. The gene discussed is CHD4; the disease is neoplasm.